1 Study Coverage
1.1 IVIG Product Introduction
1.2 Market Segments
1.3 Key IVIG Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global IVIG Market Size Growth Rate by Type
1.4.2 Injection
1.4.3 Lyophilized Powder
1.5 Market by Application
1.5.1 Global IVIG Market Size Growth Rate by Application
1.5.2 Multiple Sclerosis (MS)
1.5.3 Myasthenia Gravis (MG)
1.5.4 Multifocal Motor Neuropathy (MMN)
1.5.5 Multifocal Acquired Sensory and Motor Neuropathy (MADSAM)
1.5.6 Dermatomyositis
1.5.7 Polymyositis
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global IVIG Market Size, Estimates and Forecasts
2.1.1 Global IVIG Revenue 2015-2026
2.1.2 Global IVIG Sales 2015-2026
2.2 Global IVIG, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global IVIG Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global IVIG Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global IVIG Competitor Landscape by Players
3.1 IVIG Sales by Manufacturers
3.1.1 IVIG Sales by Manufacturers (2015-2020)
3.1.2 IVIG Sales Market Share by Manufacturers (2015-2020)
3.2 IVIG Revenue by Manufacturers
3.2.1 IVIG Revenue by Manufacturers (2015-2020)
3.2.2 IVIG Revenue Share by Manufacturers (2015-2020)
3.2.3 Global IVIG Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by IVIG Revenue in 2019
3.2.5 Global IVIG Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 IVIG Price by Manufacturers
3.4 IVIG Manufacturing Base Distribution, Product Types
3.4.1 IVIG Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers IVIG Product Type
3.4.3 Date of International Manufacturers Enter into IVIG Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global IVIG Market Size by Type (2015-2020)
4.1.1 Global IVIG Sales by Type (2015-2020)
4.1.2 Global IVIG Revenue by Type (2015-2020)
4.1.3 IVIG Average Selling Price (ASP) by Type (2015-2026)
4.2 Global IVIG Market Size Forecast by Type (2021-2026)
4.2.1 Global IVIG Sales Forecast by Type (2021-2026)
4.2.2 Global IVIG Revenue Forecast by Type (2021-2026)
4.2.3 IVIG Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global IVIG Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global IVIG Market Size by Application (2015-2020)
5.1.1 Global IVIG Sales by Application (2015-2020)
5.1.2 Global IVIG Revenue by Application (2015-2020)
5.1.3 IVIG Price by Application (2015-2020)
5.2 IVIG Market Size Forecast by Application (2021-2026)
5.2.1 Global IVIG Sales Forecast by Application (2021-2026)
5.2.2 Global IVIG Revenue Forecast by Application (2021-2026)
5.2.3 Global IVIG Price Forecast by Application (2021-2026)
6 North America
6.1 North America IVIG by Country
6.1.1 North America IVIG Sales by Country
6.1.2 North America IVIG Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America IVIG Market Facts & Figures by Type
6.3 North America IVIG Market Facts & Figures by Application
7 Europe
7.1 Europe IVIG by Country
7.1.1 Europe IVIG Sales by Country
7.1.2 Europe IVIG Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe IVIG Market Facts & Figures by Type
7.3 Europe IVIG Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific IVIG by Region
8.1.1 Asia Pacific IVIG Sales by Region
8.1.2 Asia Pacific IVIG Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific IVIG Market Facts & Figures by Type
8.3 Asia Pacific IVIG Market Facts & Figures by Application
9 Latin America
9.1 Latin America IVIG by Country
9.1.1 Latin America IVIG Sales by Country
9.1.2 Latin America IVIG Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America IVIG Market Facts & Figures by Type
9.3 Central & South America IVIG Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa IVIG by Country
10.1.1 Middle East and Africa IVIG Sales by Country
10.1.2 Middle East and Africa IVIG Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa IVIG Market Facts & Figures by Type
10.3 Middle East and Africa IVIG Market Facts & Figures by Application
11 Company Profiles
11.1 Green Cross
11.1.1 Green Cross Corporation Information
11.1.2 Green Cross Description and Business Overview
11.1.3 Green Cross Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Green Cross IVIG Products Offered
11.1.5 Green Cross Related Developments
11.2 BSV
11.2.1 BSV Corporation Information
11.2.2 BSV Description and Business Overview
11.2.3 BSV Sales, Revenue and Gross Margin (2015-2020)
11.2.4 BSV IVIG Products Offered
11.2.5 BSV Related Developments
11.3 Hualan Bio
11.3.1 Hualan Bio Corporation Information
11.3.2 Hualan Bio Description and Business Overview
11.3.3 Hualan Bio Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Hualan Bio IVIG Products Offered
11.3.5 Hualan Bio Related Developments
11.4 RAAS
11.4.1 RAAS Corporation Information
11.4.2 RAAS Description and Business Overview
11.4.3 RAAS Sales, Revenue and Gross Margin (2015-2020)
11.4.4 RAAS IVIG Products Offered
11.4.5 RAAS Related Developments
11.5 YUAN DA SHUYANG
11.5.1 YUAN DA SHUYANG Corporation Information
11.5.2 YUAN DA SHUYANG Description and Business Overview
11.5.3 YUAN DA SHUYANG Sales, Revenue and Gross Margin (2015-2020)
11.5.4 YUAN DA SHUYANG IVIG Products Offered
11.5.5 YUAN DA SHUYANG Related Developments
11.6 Kangbao Bio
11.6.1 Kangbao Bio Corporation Information
11.6.2 Kangbao Bio Description and Business Overview
11.6.3 Kangbao Bio Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Kangbao Bio IVIG Products Offered
11.6.5 Kangbao Bio Related Developments
11.7 Tiantan Bio
11.7.1 Tiantan Bio Corporation Information
11.7.2 Tiantan Bio Description and Business Overview
11.7.3 Tiantan Bio Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Tiantan Bio IVIG Products Offered
11.7.5 Tiantan Bio Related Developments
11.8 Taibang Bio
11.8.1 Taibang Bio Corporation Information
11.8.2 Taibang Bio Description and Business Overview
11.8.3 Taibang Bio Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Taibang Bio IVIG Products Offered
11.8.5 Taibang Bio Related Developments
11.9 Weiguang Bio
11.9.1 Weiguang Bio Corporation Information
11.9.2 Weiguang Bio Description and Business Overview
11.9.3 Weiguang Bio Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Weiguang Bio IVIG Products Offered
11.9.5 Weiguang Bio Related Developments
11.10 SIBP
11.10.1 SIBP Corporation Information
11.10.2 SIBP Description and Business Overview
11.10.3 SIBP Sales, Revenue and Gross Margin (2015-2020)
11.10.4 SIBP IVIG Products Offered
11.10.5 SIBP Related Developments
11.1 Green Cross
11.1.1 Green Cross Corporation Information
11.1.2 Green Cross Description and Business Overview
11.1.3 Green Cross Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Green Cross IVIG Products Offered
11.1.5 Green Cross Related Developments
11.12 RUIDE Bio
11.12.1 RUIDE Bio Corporation Information
11.12.2 RUIDE Bio Description and Business Overview
11.12.3 RUIDE Bio Sales, Revenue and Gross Margin (2015-2020)
11.12.4 RUIDE Bio Products Offered
11.12.5 RUIDE Bio Related Developments
11.13 BOYA Bio
11.13.1 BOYA Bio Corporation Information
11.13.2 BOYA Bio Description and Business Overview
11.13.3 BOYA Bio Sales, Revenue and Gross Margin (2015-2020)
11.13.4 BOYA Bio Products Offered
11.13.5 BOYA Bio Related Developments
11.14 RUIDE Bio
11.14.1 RUIDE Bio Corporation Information
11.14.2 RUIDE Bio Description and Business Overview
11.14.3 RUIDE Bio Sales, Revenue and Gross Margin (2015-2020)
11.14.4 RUIDE Bio Products Offered
11.14.5 RUIDE Bio Related Developments
11.15 Xinxing Medicine
11.15.1 Xinxing Medicine Corporation Information
11.15.2 Xinxing Medicine Description and Business Overview
11.15.3 Xinxing Medicine Sales, Revenue and Gross Margin (2015-2020)
11.15.4 Xinxing Medicine Products Offered
11.15.5 Xinxing Medicine Related Developments
11.16 Weilun Bio
11.16.1 Weilun Bio Corporation Information
11.16.2 Weilun Bio Description and Business Overview
11.16.3 Weilun Bio Sales, Revenue and Gross Margin (2015-2020)
11.16.4 Weilun Bio Products Offered
11.16.5 Weilun Bio Related Developments
11.17 WIBP
11.17.1 WIBP Corporation Information
11.17.2 WIBP Description and Business Overview
11.17.3 WIBP Sales, Revenue and Gross Margin (2015-2020)
11.17.4 WIBP Products Offered
11.17.5 WIBP Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 IVIG Market Estimates and Projections by Region
12.1.1 Global IVIG Sales Forecast by Regions 2021-2026
12.1.2 Global IVIG Revenue Forecast by Regions 2021-2026
12.2 North America IVIG Market Size Forecast (2021-2026)
12.2.1 North America: IVIG Sales Forecast (2021-2026)
12.2.2 North America: IVIG Revenue Forecast (2021-2026)
12.2.3 North America: IVIG Market Size Forecast by Country (2021-2026)
12.3 Europe IVIG Market Size Forecast (2021-2026)
12.3.1 Europe: IVIG Sales Forecast (2021-2026)
12.3.2 Europe: IVIG Revenue Forecast (2021-2026)
12.3.3 Europe: IVIG Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific IVIG Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: IVIG Sales Forecast (2021-2026)
12.4.2 Asia Pacific: IVIG Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: IVIG Market Size Forecast by Region (2021-2026)
12.5 Latin America IVIG Market Size Forecast (2021-2026)
12.5.1 Latin America: IVIG Sales Forecast (2021-2026)
12.5.2 Latin America: IVIG Revenue Forecast (2021-2026)
12.5.3 Latin America: IVIG Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa IVIG Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: IVIG Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: IVIG Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: IVIG Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key IVIG Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 IVIG Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
【掲載企業】
Green Cross、BSV、Hualan Bio、RAAS、YUAN DA SHUYANG、Kangbao Bio、Tiantan Bio、Taibang Bio、Weiguang Bio、SIBP、TONROL、RUIDE Bio、BOYA Bio、RUIDE Bio、Xinxing Medicine、Weilun Bio、WIBP
【免責事項】
https://www.globalresearch.jp/disclaimer